Sign Up Today and Learn More About Imagen Technologies Stock

Invest in or calculate the value of your shares in Imagen Technologies or other pre-IPO companies through EquityZen's platform.

Get Started

Imagen Technologies Stock

Powering the future of primary care

About Imagen Technologies Stock

Founded

2015

Headquarters

New York, NY, US

Imagen enables Primary Care providers to become technology-enabled multispecialty practices, powering a successful transition from fee-for-service to value-based care. Imagen’s comprehensive platform includes in-office diagnostic testing, diagnostic interpretations powered by proprietary FDA-cleared machine learning software, and virtual specialist consults. Imagen’s platform empowers Primary Care providers to achieve healthcare’s quadruple aim of increasing quality, lowering costs, and improving the patient and provider experience. Imagen’s team includes over 100 clinical, technical and business personnel. Imagen’s software has received first-of-its-kind FDA clearances, and its research has been published in leading peer-reviewed journals. Imagen has raised $135 million in capital from investors such as Google Ventures, Casdin Capital, and Threshold Ventures. Imagen was founded in 2015 and is based in New York City.

Imagen Technologies Press Mentions

Stay in the know about the latest news on Imagen Technologies

Imagen Technologies Management

Leadership team at Imagen Technologies

Co-Founder & Co-CEO

Alex Dresner

Co-Founder & Co-CEO

Tom Hotchkiss

Locked Features

Join now and verify your accreditation status to gain access to:

  • Imagen Technologies current valuation
  • Imagen Technologies stock price
  • Available deals in Imagen Technologies and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Imagen Technologies stock?

Accredited investors can buy pre-IPO stock in companies like Imagen Technologies through EquityZen funds. These investments are made available by existing Imagen Technologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Imagen Technologies stock?

Shareholders can sell their Imagen Technologies stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."